NCT03316261Recruiting
Freder1k-Study - Testing Infants for Type 1 Diabetes Risk
Freder1k-Study - Identification of Infants With Increased Type 1 Diabetes Risk for Enrollment Into Primary Prevention Trials
Source: ClinicalTrials.gov · Last updated 17 Dec 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The Freder1k-Study will identify infants who have a high genetic risk of type 1 diabetes.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000000 (estimated)
- First submitted
- 12 Oct 2017
- Start date
- 19 Oct 2017
- Primary completion date
- 31 Aug 2027
- Lead sponsor
- Helmholtz Zentrum München
- Diseases
- Type 1 diabetes
- NCT number
- NCT03316261
What you commit to
- Study type: Observational
- Planned participants: 1000000
- From 19 Oct 2017 to the primary completion date, 31 Aug 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \-
Who the study is looking for
- Age: up to age 6 weeks
- provided written informed consent by custodial parent
Age in the registry: 1 day to 6 weeks · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institut für Diabetesforschung, Helmholtz Zentrum München Coordinator of this site? Confirm its status | Munich | Germany | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.